• K. A. Meurer


Pheochromocytomas are catecholamine-producing tumors arising in the chromaffin cells which are of neural crest origin. They can therefore be located in the adrenal medulla as well as in the sympathetic ganglia. In the latter case, they are also called paragangliomas. The paragangliomas have been classified further by various authors according to their anatomic location and microscopic structure.43 In general, however, every catecholamine-producing tumor is classified as a pheochromocytoma, regardless of its location.


Adrenal Medulla Parathyroid Adenoma Hypertensive Crisis Malignant Pheochromocytoma Acute Intermittent Porphyria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agee OF, Kaude J, Lepasoon J (1973) Preoperative localization of pheochromocytoma. Acta Radiol Diagn 14: 545–560Google Scholar
  2. 2.
    Allen EV, Bannon WG, Upson M Jr, Huizenga KA, Bastron JA, Waugh JM (1951) A new sympatholytic and adrenalytic drug. Clinical studies on pheochromocytoma and essential hypertension. Trans Assoc Am Physicians 64: 109–121PubMedGoogle Scholar
  3. 2a.
    Armstrong, MD, McMillan A, Shaw NF (1957) 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochem Biophys Acta 25: 422–423Google Scholar
  4. 3.
    Axelrod, J, Weinshilboum R (1972) Catecholamines. N Engl J Med 287: 237–242PubMedGoogle Scholar
  5. 4.
    Ayala LA, Egdahl RH (1973) Management of pheochromocytoma: An overview of current diagnosis and treatment. Proc Natl Cancer Inst 7: 529–535Google Scholar
  6. 5.
    Berkheiser SW, Rappoport AE (1951) Unsuspected pheochromocytoma of the adrenal: Report of 5 cases. Am J Clin Path 21: 657–665PubMedGoogle Scholar
  7. 6.
    Besterman E, Bromley LL, Peart WS (1974) An intrapericardial phaeochromocytoma. Brit Heart J 36: 318–320PubMedGoogle Scholar
  8. 7.
    Bingham W, Elliot J, Lyons SM (1972) Management of anaesthesia for phaeochromocytoma. Anaesthesia 27: 49–60PubMedGoogle Scholar
  9. 8.
    Boijsen E, Williams CM, Judkins MP (1966) An-giography of pheochromocytoma. Am J Roentgenol Radium Ther Nucl Med 98: 225–232PubMedGoogle Scholar
  10. 9.
    Bolande RP (1974) The neurocristopathies. A unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 5: 409–429Google Scholar
  11. 10.
    Brunjes S, Johns VJ Jr, Crane MG (1960) Pheochromocytoma: Postoperative shock and blood volume, N Engl J Med 262: 393–396PubMedGoogle Scholar
  12. 11.
    Carney A, Sizemore GW, Sheps SG (1976) Adrenal medullary disease in multiple endocrine neoplasia, type 2. Pheochromocytoma and its precursors. Am J Clin Pathol 66: 279–290PubMedGoogle Scholar
  13. 12.
    Cone TE Jr, Allen MS, Pearson HA (1957) Pheochromocytoma in children: Report of three familial cases in two unrelated families. Pediatrics 19: 44–56PubMedGoogle Scholar
  14. 13.
    Cooperman LH, Engelman K, Mann PEG (1967) Anesthetic management of pheochromocytoma employing halothane and beta-adrenergic blockade. A report of fourteen cases. Anesthesiology 28: 575–582PubMedGoogle Scholar
  15. 14.
    Cross GO, Pace JW (1950) Malignant pheochromocytoma with paroxysmal hypertension and metastasis to the cervical spine. JAMA 142: 1068–1070Google Scholar
  16. 15.
    Crout JR, Sjoerdsma A (1959) Catecholamine excretion after banana feeding. J Pharm Pharmacol 11: 190–191PubMedGoogle Scholar
  17. 16.
    Crout JR, Sjoerdsma A (1960) Catecholamines in the localization of pheochromocytoma. Circulation 22: 516–525PubMedGoogle Scholar
  18. 17.
    Crout JR, Pisano JJ, Sjoerdsma A (1961) Urinary excretion of catecholamines and their metabolites in pheochromocytoma. Am Heart J 61: 375–381PubMedGoogle Scholar
  19. 17a.
    Crout JR (1966) Catecholamine metabolism in pheochromocytoma and essential hypertension. In: Manger WM (ed) Hormones and Hypertension. Charles C Thomas, Springfield, 111 pp 3–40Google Scholar
  20. 18.
    Crout JR, Brown BB Jr (1969) Anesthetic management of pheochromocytoma: The value of phenoxybenzamine and methoxyflurane. Anesthesiology 30: 29–36Google Scholar
  21. 19.
    Cushman P (1962) Familial endocrine tumors. Am J Med 32: 352 - 360PubMedGoogle Scholar
  22. 20.
    Darr K, Gans H, Geller J, Marks C (1969) Pheochromocytoma. Am Surg 35: 397–404PubMedGoogle Scholar
  23. 21.
    Dean RE (1958) Pheochromocytoma and pregnancy. Obstet Gynecol 11: 35–42PubMedGoogle Scholar
  24. 21a.
    DeCourcy JL, DeCourcy CB (1952) Pheochromocytomas and the General Practitioner. Barclay Newman, CincinnatiGoogle Scholar
  25. 22.
    Deoreo GA Jr, Stewart BH, Tarazi RC, Giiford RW (1974) Preoperative blood transfusion in the safe surgical management of pheochromocytoma. A review of 46 cases. J Urology 111: 715–721Google Scholar
  26. 23.
    Deutsch E, Geyer G (1975) Laboratoriumsdiagnostik. Brüder Hartmann, BerlinGoogle Scholar
  27. 23a.
    Dunnick NR, Schaner EG, Doppmann JL, Strott CA, Gill JR, Javadpour N (1979) Computed tomography in adrenal tumors. AJR 132: 43–46PubMedGoogle Scholar
  28. 24.
    Edis JA, Ayala LA, Egdahl RH (1975) Manual of Endocrine Surgery. Springer-Verlag, New York Heidelberg, BerlinGoogle Scholar
  29. 25.
    Eisenberg AA, Wallerstein H (1932) Pheochromocytoma of the suprarenal medulla (paraganglioma). Arch Pathol 14: 818–836Google Scholar
  30. 26.
    El-Minawi MF, Paulino E, Cuesta M, Ceballos J (1971) Pheochromocytoma masquerading as preeclamptic toxemia. Am J Obstet Gynecol 109: 389–395PubMedGoogle Scholar
  31. 27.
    Engelman K, Sjoerdsma A (1964) Chronic medical therapy for pheochromocytoma. A report of four cases. Ann Intern Med 61: 229–241PubMedGoogle Scholar
  32. 28.
    Engelman K, Zelis R, Waldmann T, Mason DT, Sjoerdsma A (1968) Mechanism of orthostatic hypotension in pheochromocytoma. Circulation 38 (Suppl. VI): 72Google Scholar
  33. 29.
    Engelman K (1969) Principles in the diagnosis of pheochromocytoma. Bull NY Acad Med 45: 851–858Google Scholar
  34. 30.
    Engelman K (1977) Phaeochromocytoma. Clin Endocrinol Metabol 6: 769–797Google Scholar
  35. 31.
    Essers U, Mühlhoff G, Rahn KH, Ochs G (1977) Erhöhte Erythropoetinsekretion bei Phäochromozytom. Med Welt 28: 877–881PubMedGoogle Scholar
  36. 32.
    Euler US von (1954) III. Epinephrine and norepinephrine: Adrenaline and noradrenaline. Distribution and action. Pharmacol Rev 6: 15–22Google Scholar
  37. 33.
    Euler US von, Gemzell CA, Ström G, Westman A (1955) Report of a case of pheochromocytoma, with special regard to preoperative diagnostic problems. Acta Med Scand 153: 127–136Google Scholar
  38. 34.
    Euler US von, Ström G (1957) Present status of diagnosis and treatment of pheochromocytoma. Circulation 15: 5–13Google Scholar
  39. 35.
    Faivre G, Sommelet J, Gilgenkrantz JM, Cherrier F, Masse G (1962) Topographical diagnosis of a pheochromocytoma by determination of catecholamines at various levels of the vena caval system. Bull Soc Med Hop (Paris) 113: 129–137Google Scholar
  40. 36.
    Farquhar JW (1958) Pheochromocytoma in childhood: Case report and a brief review of 56 others recorded in the literature. JR Coll Surg Edinburgh 3: 300–310Google Scholar
  41. 37.
    Fox LP, Grandi J, Johnson AH, Watrous WG, Johnson MJ (1969) Pheochromocytoma associated with pregnancy. Am J Obstet Gynecol 104: 288–295PubMedGoogle Scholar
  42. 38.
    Fries JG, Chamberlin JA (1968) Extra-adrenal pheochromocytoma: Literature review and report of a cervical pheochromocytoma. Surgery 63: 268–279Google Scholar
  43. 39.
    Gemmell AA (1955) Phaeochromocytoma and the obstetrician. J Obstet Gynaecol Brit Commonw 62: 195–202Google Scholar
  44. 40.
    Gilford RW Jr, Kvale WF, Maher FT, Roth GM, Priestly JT (1964) Clinical features, diagnosis and treatment of pheochromocytoma: A review of 76 cases. Mayo Clin Proc 39: 281–302Google Scholar
  45. 40a.
    Gitlow SE, Mendlowitz M, Kruk E, Khassis S (1961) Diagnosis of pheochromocytoma by assay of catecholamine metabolites. Circ Res 9: 746–754PubMedGoogle Scholar
  46. 41.
    Gitlow SE, Mendlowitz M, Bertani LM (1970) The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. A review of ten years’ experience. Am J Cardiol 26: 270–279Google Scholar
  47. 42.
    Glenn, F (1971) Surgical treatment of chromaffin tumors. Am Surg 37: 6–11PubMedGoogle Scholar
  48. 43.
    Glenner GG, Grimley PM (1974) Tumors of the extraadrenal Paraganglion system (including chemoreceptors). In: Atlas of Tumor Pathology, 2nd series, fascicle 9. Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  49. 43a.
    Goldberg LJ (1972) Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol Rev 24: 7–29Google Scholar
  50. 44.
    Goldfien A (1963) Pheochromocytoma: Diagnosis and anesthetic and surgical management. Anesthesiology 24: 462–471PubMedGoogle Scholar
  51. 45.
    Goodall McC, Stone C (1960) Adrenaline and noradrenaline producing tumors of the adrenal medulla and sympathetic nerves. Ann Surg 151: 391–398PubMedGoogle Scholar
  52. 46.
    Graham JB (1951) Pheochromocytoma and hypertension. An analysis of 207 cases. Int Abstr Surg 92: 105–121PubMedGoogle Scholar
  53. 47.
    Grenzmann M, Thum P (1969) Der Wert der Röntgenuntersuchung bei inkretorisch wirksamen Nebennierenerkrankungen. Fortschr Röntgenstr 111: 353Google Scholar
  54. 48.
    Griffith MI, Felts JH, James FM, Meyers RT, Shealy GM, Woodruff LF Jr (1974) Successful control of pheochromocytoma in pregnancy. JAMA 229: 437–439PubMedGoogle Scholar
  55. 49.
    Harrison TS, Bartlett JD Jr, Seaton JF (1968) Current evaluation and management of pheochromocytoma. Ann Surg 168: 701–713PubMedGoogle Scholar
  56. 50.
    Harrison TS, Freier DT (1974) Pitfalls in the technique and interpretation of regional venous sampling for localizing pheochromocytoma. Surg Clin North Am 54: 339–347PubMedGoogle Scholar
  57. 51.
    Harrison TS, Freier DT, Cohen EL (1974) Recurrent pheochromocytoma. Arch Surg 108: 450–454PubMedGoogle Scholar
  58. 52.
    Helber A, Dvorak K, Winkelmann K, Meurer KA, Würz H, Dickmans A (1975) 131 J-Cholesterin-Szintigraphie der Nebennieren. Dtsch Med Wschr 100: 2525–2527Google Scholar
  59. 53.
    Hiner LB, Gruskin AB, Baluarte HJ, Cote ML, Sapire DW, Levitsky D (1976) Plasma renin activity and intrarenal blood flow distribution in a child with a pheochromocytoma. J Pediat 89: 950–952PubMedGoogle Scholar
  60. 54.
    Hume DM (1960) Pheochromocytoma in the adult and in the child. Am J Surg 99: 458–496PubMedGoogle Scholar
  61. 55.
    Huston Jr, Stewart WRC (1965) Hemorrhagic pheochromocytoma with shock and abdominal pain. Am J Med 39: 502–604Google Scholar
  62. 55a.
    Hyman A, Mencher WH (1943) Pheochromocytoma of the adrenal gland. J Urol 49: 755–771Google Scholar
  63. 56.
    Iversen LL (1975) Dopamine receptors in the brain: A dopamine-sensitive adenylate cyclase models synaptic receptors illuminating antipsychotic drug action. Science 188: 1084–1089PubMedGoogle Scholar
  64. 57.
    Johns VJ Jr, Brunjes S (1962) Pheochromocytoma. Am J Cardiol 9: 120–125PubMedGoogle Scholar
  65. 58.
    Juno P (1977) Intraoperative management of pheochromocytoma. Minn Med 60: 22–24PubMedGoogle Scholar
  66. 59.
    Kalff G (1968) Anesthesiologische Probleme bei Patienten mit Phäochromozytom. Anaesthesist 17: 43–47PubMedGoogle Scholar
  67. 60.
    Kirkendall WM, Liechty RD, Gulp DA (1965) Diagnosis and treatment of patients with pheochromocytoma. Arch Intern Med 115: 529PubMedGoogle Scholar
  68. 61.
    Kitajima W, Saruta T, Kondo K, Yamada R, Aoki S, Nagakubo I (1975) A case of secondary aldosteronism induced by pheochromocytoma. J Urol 114: 141–143PubMedGoogle Scholar
  69. 62.
    Kline IK (1961) Myocardial alterations associated with pheochromocytomas. Am J Pathol 38: 539–552PubMedGoogle Scholar
  70. 62a.
    Koll JF, Sack H (1962) EKG-Veränderungen beim Phaeochromocytom. Forum cardiologicum 4:61–95 Hrsg CF Boehringer, MannheimGoogle Scholar
  71. 63.
    Kopin IJ (1977) Catecholamine metabolism (and the biochemical assessment of sympathetic activity). Clin Endocrinol Metab 6: 525–549PubMedGoogle Scholar
  72. 64.
    Lang R, Meurer KA, Kaufmann W (1977) Rezidivierendes Phäochromozytom. Med Welt 18: 157–165Google Scholar
  73. 65.
    Lang R, Mödder U, Moritz G, Meurer KA, Helber A, Dvorak K (1978) Die Lokalisationsdiagnostik der Phäochromozytome. Inn Med 5: 225–240Google Scholar
  74. 66.
    Lanner LO, Rosencrantz M (1970) Artériographie appearance of phaeochromocytoma. Acta Radiol (Diagn) 10: 35–48Google Scholar
  75. 66a.
    Linde P (1924) Unusual tumor (pheochromocytoma) in infant 5 months old. Nord Med 12: 897Google Scholar
  76. 67.
    Louis WJ, Doyle AE (1971) The use of a double- isotope derivate plasma assay for noradrenaline and adrenaline in the diagnosis and localization of pheochromocytoma. Aust NZ J Med 3: 212–217Google Scholar
  77. 68.
    Maebashi M, Miura Y, Yoshinaga K, Sato K (1968) Plasma renin activity in pheochromocytoma. Jpn Circ J 32: 1427–1432PubMedGoogle Scholar
  78. 69.
    Mahaux JE, deSchaepdryver AF, Veriniory A, Enderle J, Smets W, Reinhold H, deRood M, Meunier A (1963) Pheochromocytoma with pseudohyper- thyroid symptoms. Localisation of the tumor by retropneumoperitoneum and by graded determination in the inferior vena cava. Ann Endocrinol 24: 93–101Google Scholar
  79. 70.
    Manger WM, Wakim KG (1966) The role of nor-epinephrine in the etiology of diastolic hypertension. In: Manger WM (ed) Hormones and Hypertension. Charles C Thomas, Springfield, 111, chap 2, pp 41–86Google Scholar
  80. 70a.
    Manger WM, Gifford RW Jr (1977) Pheochromocytoma. Springer-Verlag, New York, Berlin, HeidelbergGoogle Scholar
  81. 71.
    Manning PC Jr, Molnar GD, Black BM, Priestly JT, Woolner LB (1963) Pheochromocytoma, hyperparathyroidism and thyroid carcinoma occurring coincidentally. N Engl J Med 268: 68–72Google Scholar
  82. 72.
    Metz SA, Levine RJ (1977) Neuroendocrine tumors that secrete biologically active peptides and amines. Clin Endocrinol Metab 6: 719–744PubMedGoogle Scholar
  83. 73.
    Meurer KA (1970) Renin-Angiotensin-Aldosteron System und Pharmaka. Med Welt 21: 1631–1650Google Scholar
  84. 74.
    Meurer KA, Lang R, Kaufmann W (1975) Das Phäochromozytom. Nieren- und Hochdruckkrankheiten 5: 187–197Google Scholar
  85. 75.
    Meyers MA, King MC (1969) Unusual radiologic features of pheochromocytoma. Clin Radiol 20: 52PubMedGoogle Scholar
  86. 76.
    Minno AM, Bennett WA, Kvale WF (1954) Pheochromocytoma. A study of 15 cases diagnosed at autopsy. N Engl J Med 251: 959–965PubMedGoogle Scholar
  87. 77.
    Mühlhoff G, Sack H, Schega W (1975) Das Phäochromozytom. Chirurg 46: 210–215PubMedGoogle Scholar
  88. 78.
    Nakada T, Momose G, Yoshida T (1968) Diagnosis of adrenal hypertension.I.Selective adrenal venography and pharmacological evaluation using catheter technique for detecting pheochromocytoma. J Urol 109: 757–760Google Scholar
  89. 79.
    Neimann N, Peirson M, Lesure L, Vert P, Gilgencrantz G (1959) Pheochromocytoma in a 10-year-old girl. Topographic diagnosis by determination of blood catecholamines at different levels. Arch Fr Pediat 16: 1372–1377PubMedGoogle Scholar
  90. 80.
    öhmann U, Granberg PO, Hjern B, Sjöberg HE (1974) Pheochromocytoma. Acta Chir Scand 140: 660–666Google Scholar
  91. 81.
    Pearse AGE (1968) Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc Roy Soc London (ser B) 170: 71–80Google Scholar
  92. 82.
    Pearse AGE (1972) The genesis of APUD amyloid in endocrine polypeptide tumors: Histochemical distinction from immunoamyloid. Virchows Arch B10: 93–107Google Scholar
  93. 83.
    Pekkarinen A, Scheinin TM, Näntö V (1967) Localization of pheochromocytoma by vena caval catheterization and determination of plasma catecholamines. Ann Chir Gynaecol Fenn 56: 419–423PubMedGoogle Scholar
  94. 84.
    Perlman RL, Chalfie M (1977) Catecholamine release from the adrenal medulla. Clin Endocrinol Metab 6: 551–576PubMedGoogle Scholar
  95. 85.
    Perrin A, Mornex R, Mansuy L, Airmard G, Thomas M (1969) Pheochromocytome intraarachnidien. Rev Lyon Med 18: 557–580Google Scholar
  96. 85a.
    Pick L (1912) Das Ganglioma embryonale sympathicum (Sympathoma embryonale) eine typische bösartige Geschwulstform des sympathischen Nervensystems. Berl Klin Wschr 49: 16–22Google Scholar
  97. 86.
    Pochedly C (1976) Neuroblastoma. Publishing Science Group, Acton, MassGoogle Scholar
  98. 87.
    Prichard BNC, Ross EJ (1966) Use of propranolol in conjunction with alpha-receptor blocking drugs in pheochromocytoma. Am J Cardiol 18: 394–398PubMedGoogle Scholar
  99. 88.
    Remine WH, Chong GC, vanHeerden JA, Sheps SG, Harrison EG Jr (1974) Current management of pheochromocytoma. Ann Surg 179: 740–748PubMedGoogle Scholar
  100. 89.
    Richards V, Hatch FN (1957) Surgical experiences with pheochromocytoma. Ann Surg 134: 40–54Google Scholar
  101. 90.
    Richmond J, Frazer SC, Milar DR (1961) Paroxysmal hypotension due to an adrenaline-secreting phaeochromocytoma. Lancet 2: 904–906PubMedGoogle Scholar
  102. 91.
    Robertson AIG (1962) Anesthetic management of phaeochromocytoma. Proc Roy Soc Med 55: 432–436PubMedGoogle Scholar
  103. 92.
    Rosenberg JC, Varco RL (1967) Physiologic and pharmacologic considerations in the management of phaeochromocytoma. Surg Clin North Amer 47: 1453–1460Google Scholar
  104. 93.
    Ross EJ, Prichard BNC, Kaufman L, Robertson AIG, Harries BJ (1967) Preoperative and operative managements of patients with pheochromocytoma. Brit Med J 1: 191–198PubMedGoogle Scholar
  105. 94.
    Rossi P, Young IS, Panke EF (1968) Techniques, usefulness, and hazards of arteriography in pheochromocytoma. A review of 99 cases. JAMA 205: 547–553PubMedGoogle Scholar
  106. 95.
    Sack H, Roll FJ (1963) Das Phäochromocytom. Ergeb Inn Med Kinderheilk 19: 446Google Scholar
  107. 96.
    Sadove MS, Cadkin LM (1970) Pheochromocytoma: Total patient management. Surg Clin North Amer 50: 147–155Google Scholar
  108. 97.
    Saint-Pierre A, Perrin A, Mornex R, Pouzeratte JP (1970) Les troubles du rythme cardiaque dus aux pheochromocytomes (et forme rythmique pure). Coeur et Med Interne 9: 3–11Google Scholar
  109. 98.
    Sayer WJ, Moser M, Mattingly TW (1954) Pheochromocytoma and the abnormal electrocardiogram. Am Heart J 48: 42–53PubMedGoogle Scholar
  110. 99.
    Schäfer EL (1959) Hypertonie bei hormonalen Erkrankungen und ihre Therapie. Med Welt 39: 1824Google Scholar
  111. 100.
    Schega W, Josefiak K, Körner M (1973) Die operative Behandlung des Phäochromocytoms. Med Klin 68: 1423–1426PubMedGoogle Scholar
  112. 101.
    Schlegel GG von (1960) Neurofibromatose Recklinghausen und Phäochromocytom. Schweiz Med Wschr 90: 31–39PubMedGoogle Scholar
  113. 102.
    Schnelle N, Ferris DO, Schirger A (1964) The use of blood volume determination in patients undergoing surgery for pheochromocytoma. Anesth Analg (Cleveland) 43: 641–645Google Scholar
  114. 103.
    Scott HW Jr, Oates JA, Nies AS, Burko H, Page DL, Rhamy RK (1976) Pheochromocytoma: Present diagnosis and management. Ann Surg 183: 587–593PubMedGoogle Scholar
  115. 103a.
    Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163-166 103b. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwaltes WH, Thompson NW (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305: 12–17Google Scholar
  116. 104.
    Sjoerdsma A (1960) Newer biochemical approaches to treatment of hypertension. Ann NY Acad Sci 88: 933–938Google Scholar
  117. 105.
    Sjoerdsma A, Engelman K, Waldmann TA, Cooperman LH, Hammond WG (1966) Pheochromocytoma: Current concepts of diagnosis and treatment. Ann Intern Med 65: 1302–1325Google Scholar
  118. 106.
    Smith AM (1973) Phaeochromocytoma and pregnancy. J Obstet Gynaecol 80: 848–851Google Scholar
  119. 107.
    Smithwick RH (1950) Surgical measures in hypertension. In: DeBakey M, Spurling RG (eds) American Lectures in Surgery. Charles C Thomas, Springfield, 111Google Scholar
  120. 107a.
    Spergel G, Levy L, Chowdhury FR, Rodman HM, Ertel NH, Bleicher SJ (1970) A modified phentolamine test for diagnosis of pheochromocytoma. JAMA 211: 266–269PubMedGoogle Scholar
  121. 108.
    Stackpole RH, Melicow MM, Uson AC (1963) Pheochromocytoma in children. J Pediat 63: 315–330Google Scholar
  122. 109.
    Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: Multiple endocrine neoplasia, type 2. Medicine 47: 371–409PubMedGoogle Scholar
  123. 110.
    Sturman MF, Moses DC, Beierwaltes WH, Harrison TS, Ice RD, Dorr RP (1974) Radiocholesterol adrenal images for the localisation of pheochromocytoma. Surg Gynecol Obstet 138: 177–180PubMedGoogle Scholar
  124. 111.
    Symington T, Goodall AL (1953) Studies in phaeochromocytoma: I. Pathological aspects. Glasgow Med J 34: 75–96PubMedGoogle Scholar
  125. 112.
    Tarazi RC, Dustan HP, Fröhlich ED, Gifford RW Jr, Hoffman GC (1970) Plasma volume and chronic hypertension. Relationship to arterial pressure levels in diflferent hypertensive diseases. Arch Intern Med 125: 835–842PubMedGoogle Scholar
  126. 113.
    Taubman I, Pearson OH, Anton AH (1974) An asymptomaticcatecholamine-secretingpheochromocytoma. Am J Med 57: 953–956PubMedGoogle Scholar
  127. 114.
    Temple WJ, Voitik A J, Thomson AE, Downs AR (1977) Phenoxybenzamine blockade in surgery of pheochromocytoma. J Surg Res 22: 59–64PubMedGoogle Scholar
  128. 115.
    Vetter H, Vetter W, Warnholz C, Bayer J-M, Käser K, Vielhaber K, Krück F (1976) Renin and aldosterone secretion in pheochromocytoma. Effect of chronic alpha-adrenergic receptor blockade. Am J Med 60: 866–871PubMedGoogle Scholar
  129. 116.
    Van Vliet PD, Burchell HB, Titus JL (1966) Focal myocarditis associated with pheochromocytoma. N Engl J Med 274: 1102–1108PubMedGoogle Scholar
  130. 117.
    Voorhess, ML (1968) The catecholamines in tu-mour and urine from patients with neuroblastoma, ganglioneuroblastoma and pheochromocytoma. J Pediat Surg 3: 147–148PubMedGoogle Scholar
  131. 118.
    Voute PA, Wadman SK, vanPutten WJ (1970) Congenital neuroblastoma. Symptoms in the mother during pregnancy. Clin Pediat 9: 206–207PubMedGoogle Scholar
  132. 119.
    Waldmann TA, Bradley JE (1961) Polycythemia secondary to a pheochromocytoma with production of an erythropoiesis-stimulating factor by the tumor. Proc Soc Exp Biol Med 108: 425–427PubMedGoogle Scholar
  133. 120.
    Weil-Malherbe H (1956) Phaeochromocytoma: catechols in urine and tumour tissue. Lancet 2: 282–284Google Scholar
  134. 121.
    Werning C, Ziegler WH, Baumann K, Enders P, Gysling E, Weidmann P, Siegenthaler W (1970) Die Plasma-Renin-Aktivität beim Phäochromozytom. Dtsch Med Wschr 95: 117–125PubMedGoogle Scholar
  135. 122.
    Werning C, Siegenthaler W (1977) Krankheiten des Nebennierenmarkes. In: Hornborstel H, Kaufmann W, Siegenthaler W (eds) Innere Med. in Praxis und Klinik. Thieme 4: 110–125Google Scholar
  136. 123.
    Wilson RJ, Craig GM, Mills IH (1973) Metabolie studies in a patient with a phaeochromocytoma associated with hypokalemia and hyperaldosteronism. J Endocrinol 56: 69–78PubMedGoogle Scholar
  137. 124.
    Zelch JV, Meaney TF, Belhobek GH (1974) Radiologic approach to the patient with suspected pheochromocytoma. Radiology 111: 279–284Google Scholar
  138. 125.
    Ziegler WH (1977) Diagnostische Maβnahmen bei Phäochromozytom. Dtsch Med Wschr 102: 325–327PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1982

Authors and Affiliations

  • K. A. Meurer

There are no affiliations available

Personalised recommendations